News Online
  • Sign in
  • News
    • Africa
    • Americas
      • Law
      • Politics
        • 2020 Election
    • Asia
    • Australia
    • Canada
    • China
    • Europe
    • India
    • Latin America
    • Middle East
      • Israel
        • Israel Election
    • Russia
    • UK
  • Economy
    • Business
    • Health
      • Medicine
    • Industrial
    • Markets
    • Real Estate
    • Small Business
    • Startup
  • Science & Technology
    • Apps
    • Cameras
    • Space
    • Computers
    • Phones
    • Gadgets
    • Internet
  • Food & Drinks
    • Restaurants
  • Culture
    • Art
    • Books
    • Celebrity
    • Movies
    • Music
    • TV
  • LifeStyle
    • Autos
    • Fitness
    • Fashion
      • Beauty
    • Design
  • Sports
    • American Football
    • Athletics
    • Bastketball
    • Cycling
    • Football
    • Golf
    • Motorsport
      • Formula 1
      • Indycar
      • Nascar
    • Tennis
  • Travel
    • Africa
    • Asia
      • Thiland
    • Europe
    • India
    • Middle East
      • Israel
    • North America
    • South America
    • UK & Ireland
    • United States
  • Login
Menu
  • Sign in
  • News
    • Africa
    • Americas
      • Law
      • Politics
        • 2020 Election
    • Asia
    • Australia
    • Canada
    • China
    • Europe
    • India
    • Latin America
    • Middle East
      • Israel
        • Israel Election
    • Russia
    • UK
  • Economy
    • Business
    • Health
      • Medicine
    • Industrial
    • Markets
    • Real Estate
    • Small Business
    • Startup
  • Science & Technology
    • Apps
    • Cameras
    • Space
    • Computers
    • Phones
    • Gadgets
    • Internet
  • Food & Drinks
    • Restaurants
  • Culture
    • Art
    • Books
    • Celebrity
    • Movies
    • Music
    • TV
  • LifeStyle
    • Autos
    • Fitness
    • Fashion
      • Beauty
    • Design
  • Sports
    • American Football
    • Athletics
    • Bastketball
    • Cycling
    • Football
    • Golf
    • Motorsport
      • Formula 1
      • Indycar
      • Nascar
    • Tennis
  • Travel
    • Africa
    • Asia
      • Thiland
    • Europe
    • India
    • Middle East
      • Israel
    • North America
    • South America
    • UK & Ireland
    • United States
  • Login
Search
Close this search box.
  • Sign in
  • News
    • Africa
    • Americas
      • Law
      • Politics
        • 2020 Election
    • Asia
    • Australia
    • Canada
    • China
    • Europe
    • India
    • Latin America
    • Middle East
      • Israel
        • Israel Election
    • Russia
    • UK
  • Economy
    • Business
    • Health
      • Medicine
    • Industrial
    • Markets
    • Real Estate
    • Small Business
    • Startup
  • Science & Technology
    • Apps
    • Cameras
    • Space
    • Computers
    • Phones
    • Gadgets
    • Internet
  • Food & Drinks
    • Restaurants
  • Culture
    • Art
    • Books
    • Celebrity
    • Movies
    • Music
    • TV
  • LifeStyle
    • Autos
    • Fitness
    • Fashion
      • Beauty
    • Design
  • Sports
    • American Football
    • Athletics
    • Bastketball
    • Cycling
    • Football
    • Golf
    • Motorsport
      • Formula 1
      • Indycar
      • Nascar
    • Tennis
  • Travel
    • Africa
    • Asia
      • Thiland
    • Europe
    • India
    • Middle East
      • Israel
    • North America
    • South America
    • UK & Ireland
    • United States
  • Login
Menu
  • Sign in
  • News
    • Africa
    • Americas
      • Law
      • Politics
        • 2020 Election
    • Asia
    • Australia
    • Canada
    • China
    • Europe
    • India
    • Latin America
    • Middle East
      • Israel
        • Israel Election
    • Russia
    • UK
  • Economy
    • Business
    • Health
      • Medicine
    • Industrial
    • Markets
    • Real Estate
    • Small Business
    • Startup
  • Science & Technology
    • Apps
    • Cameras
    • Space
    • Computers
    • Phones
    • Gadgets
    • Internet
  • Food & Drinks
    • Restaurants
  • Culture
    • Art
    • Books
    • Celebrity
    • Movies
    • Music
    • TV
  • LifeStyle
    • Autos
    • Fitness
    • Fashion
      • Beauty
    • Design
  • Sports
    • American Football
    • Athletics
    • Bastketball
    • Cycling
    • Football
    • Golf
    • Motorsport
      • Formula 1
      • Indycar
      • Nascar
    • Tennis
  • Travel
    • Africa
    • Asia
      • Thiland
    • Europe
    • India
    • Middle East
      • Israel
    • North America
    • South America
    • UK & Ireland
    • United States
  • Login
News Online
Search
Close this search box.
  • 07/07/2025 17:20 The right—and wrong—way for bosses to apologize: ‘Timing is everything,’ says communication expert
  • 07/07/2025 17:20 How Netflix keeps luring big-name directors away from the traditional box office
  • 07/07/2025 17:20 America’s Deficit Reckoning: How the U.S. debt spiral could spark a crisis
  • 07/07/2025 15:20 Romance Reads for Disability Pride Month!
  • 07/07/2025 15:20 Must-Read Summer Books, BIPOC Edition
  • 07/07/2025 13:20 ‘Roundball Rock’ Creator John Tesh Stoked for Iconic Tune’s Return to NBA on NBC
  • 07/07/2025 13:20 Guess Who This Kid by the Pool Turned Into!
  • 07/07/2025 11:20 Protests against foreigners, ex-pats, gentrifiers, ‘gringos’ turn violent in Mexico City
  • 07/07/2025 11:19 UK pop star Lily Allen ‘can’t remember exactly how many’ abortions she’s had
  • 07/07/2025 11:19 Tropical Storm Chantal Floods Parts of North Carolina
Antibody-drug combination outperforms standard treatment of advanced triple-negative breast cancer
Home » Business » Health » Antibody-drug combination outperforms standard treatment of advanced triple-negative breast cancer

Antibody-drug combination outperforms standard treatment of advanced triple-negative breast cancer

Thomas Menjivar 02/06/2025 17:20

In patients with an aggressive form of breast cancer, treatment with the antibody-drug conjugate sacituzumab govitecan plus pembrolizumab resulted in durable responses with improved progression free survival compared to the current standard treatment. The ASCENT-04 study presented today by Dana-Farber Cancer Institute investigators evaluated patients receiving their first treatment for advanced or metastatic triple negative

Medical Xpress
In patients with an aggressive form of breast cancer, treatment with the antibody-drug conjugate sacituzumab govitecan plus pembrolizumab resulted in durable responses with improved progression free survival compared to the current standard treatment. The ASCENT-04 study presented today by Dana-Farber Cancer Institute investigators evaluated patients receiving their first treatment for advanced or metastatic triple negative breast cancer that tests positive for the immune checkpoint PD-L1…
Read More

About the Author

View all posts by Thomas Menjivar


« Previous Post
Next Post »
Folow Us
  • Facebook
  • Twitter
  • YouTube
  • LinkedIn
  • Pinterest
  • Instagram
News Live
Popular
The yearning for peace: A story of Israeli childhood under fire
Israel
07/07/2025 Comments Off on The yearning for peace: A story of Israeli childhood under fire
After IDF strikes on targets in Yemen, Houthi rebels fire ballistic missiles at Israel
Israel
07/07/2025 Comments Off on After IDF strikes on targets in Yemen, Houthi rebels fire ballistic missiles at Israel
Editor picks

The yearning for peace: A story of Israeli childhood under fire

07/07/2025 Randy Kucera

The yearning for peace: A story of Israeli childhood under fire...

After IDF strikes on targets in Yemen, Houthi rebels fire ballistic missiles at Israel

07/07/2025 Laine Catt

After IDF strikes on targets in Yemen, Houthi rebels fire ballistic missiles at Israel...

Israel responds to growing threat of Chinese smart device espionage

07/07/2025 Lyndia Drews

Israel responds to growing threat of Chinese smart device espionage...

Follow Us
Tweets by @NewsOnlineApp
Like Us
Services

Advertise With Us

Display Advertising

No posts found.

About

About us

Contact us

Privacy Policy

 

© NEWS Online
Scroll to top

This website uses cookies to ensure you get the best experience on our website.

got it
Skip to content
Open toolbar Accessibility Tools

Accessibility Tools

  • Increase TextIncrease Text
  • Decrease TextDecrease Text
  • GrayscaleGrayscale
  • High ContrastHigh Contrast
  • Negative ContrastNegative Contrast
  • Light BackgroundLight Background
  • Links UnderlineLinks Underline
  • Readable FontReadable Font
  • Reset Reset